The information we have available from both sides of the Atlantic strongly supports the ¢ndings reported by Gordon et al. 1 Although no formal publications exist to date, the observation of green colour on guaiac-based faecal occult blood tests (FOBT) has been reported and discussed anecdotally. The most likely origin of the colour has been considered to be the presence of bile. Since bile does not react with the guaiac, such green colours are observed to migrate away from the faecal specimen to the periphery of guaiac-impregnated paper when the developer is applied.
Our concern was that, on occasion, such green colours could mask the true presence of occult blood and could result in misinterpretation of the test result. In-house tests with blood dilutions or with spiked samples using our Hema-screen product have always displayed spreading of colour away from the area where the sample was applied, but this was never washed away entirely towards the periphery.
Based on the report of Gordon et al. 1 and the above observations, we concur with the recommendations that a test result should be considered positive if the green colour did not wash out entirely to the periphery of the guaiac paper. Conversely, if such colour does wash out, the result should be interpreted as negative.
The correct interpretation of FOBT results as described by Gordon et al. 1 could potentially result in the saving of lives, while avoiding unnecessary, uncomfortable and expensive colonoscopies for those with no blood, but bile, in their faeces.We have changed the instruction sheets of our guaiac-based FOBT products accordingly. Green-coloured results on guaiac-based faecal occult blood testing should be considered positive I read with great interest the Short Report 'Greencoloured results on guaiac-based faecal occult blood testing should be considered positive' 1 in this journal, and I wish to raise some points regarding the (pre)analytical procedure and interpretation of faecal occult blood testing (FOBT).We have been involved in FOBT for about 25 years and have used a lot of commercially available guaiac-based tests, each of which has (sometimes confusing) recommendations and instructions concerning dietary measures, analytical manipulations, and the interpretation and evaluation of results. We are now using the Hemoccult guaiac test as modi¢ed by Greegor (Beckman-Coulter Ireland Inc., Marvue, Galway, Ireland), which is also the reference test for occult blood in faeces for the German early cancer detection programme. The instructions for use are interesting because the dietary restrictions for red meat are unnecessary (but black pudding should probably be avoided). Other restrictions are as usual for FOBTs (vitamin C, etc.). Development of the slides not earlier than 48 h after the last stool sample has been applied is recommended. After applying two drops in the centre of the stool specimen area covered by guaiac paper in two rounds, the third and fourth drops may be applied if the outer ring of the moist circle has not left the area of the stool specimen. The results must be read within 60 s: the product information states that any blue on or at the edge of the specimen seen during this time period, irrespective of its intensity, indicates a positive result. No information is given for a blue-green or distinctly green colour that may be due to bile.
Our experience with the Hemoccult guaiac test is that about 30% of all positive tests develop a green colour.We use a combined approach 2 by con¢rming positive and problematic FOBT results with immoCARE-C rapid immunochromatographic assay (CARE Diagnostica, Producktions-und Vertriebgesellschaft m.b.H., Moellersdrof, Austria) for immunochemical detection of intact human haemoglobin or its early degradation products. The majority (495%) of specimens with a green colour are positive with immunochemical testing.
FOBT screening is currently the recommended screening method, with follow-up of positive tests by colonoscopy or other visualization techniques, and FOBT should therefore be accurate and sensitive enough to achieve a high analytic and diagnostic accuracy for cancers and precancerous colorectal neoplasia. In our opinion the guaiac-based tests, even socalled 'reference' or 'sensitive' tests, do not meet these requirements: they are problematic considering the preanalytical, analytical, and postanalytical points of view (especially the interpretation of spurious colour) and the high false-positive and false-negative rates. The only screening that may reach the necessary diagnostic sensitivity and speci¢city with clinically relevant positive and negative predictive values is immunochemical testing without any special dietary adjustment or specimen preparation, including delay of testing. Such screening is, in our opinion, more cost-e¡ective than guaiac testing or a combined guaiac and immunochemical approach because it cuts down on unnecessary and expensive retesting and follow-up procedures.
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